Literature DB >> 2825646

Effects of forskolin on contractile responses and protein phosphorylation in the isolated perfused rat heart.

P J England1, M Shahid.   

Abstract

Continuous perfusion of rat hearts with concentrations of forskolin between 0.1 and 12 microM resulted in transient increases in tension after 45 s, followed by a return to the control value after 5 min. In contrast, the content of cyclic AMP increased linearly with time over this period, reaching values up to 35 times control after 5 min. Increases in contractile force, intracellular cyclic AMP concentration and the proportion of phosphorylase in the a form were dependent on the concentration of forskolin when measured 45 s and 120 s after initiation of perfusion. In hearts perfused for 45 s with various concentrations of forskolin, the measured cyclic AMP-dependent protein kinase activity ratio and phosphorylase a content for a given measured intracellular cyclic AMP concentration were both much less than the corresponding values in hearts perfused for 30 s with various concentrations of isoprenaline. The phosphorylation of the contractile proteins troponin-I and C-protein also showed a concentration-dependent increase in hearts perfused with forskolin. There was a strong correlation between the cyclic AMP-dependent protein kinase activity ratios and the phosphorylation of the contractile proteins under all perfusion conditions. These results suggest that cyclic AMP is compartmented in perfused rat heart, and that much of the cyclic AMP produced in response to forskolin is unavailable to activate cyclic AMP-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825646      PMCID: PMC1148333          DOI: 10.1042/bj2460687

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Phosphorylation of a myofibrillar protein of Mr 150 000 in perfused rat heart, and the tentative indentification of this as C-protein.

Authors:  S A Jeacocke; P J England
Journal:  FEBS Lett       Date:  1980-12-15       Impact factor: 4.124

4.  Injection of subunits of cyclic AMP-dependent protein kinase into cardiac myocytes modulates Ca2+ current.

Authors:  W Osterrieder; G Brum; J Hescheler; W Trautwein; V Flockerzi; F Hofmann
Journal:  Nature       Date:  1982-08-05       Impact factor: 49.962

Review 5.  Cyclic-AMP-dependent phosphorylation of cardiac contractile proteins.

Authors:  P J England; H T Pask; D Mills
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

6.  The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin.

Authors:  S P Robertson; J D Johnson; M J Holroyde; E G Kranias; J D Potter; R J Solaro
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

7.  The phosphorylation of troponin I from cardiac muscle.

Authors:  H A Cole; S V Perry
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

8.  Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin.

Authors:  E Lindner; A N Dohadwalla; B K Bhattacharya
Journal:  Arzneimittelforschung       Date:  1978

9.  Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart.

Authors:  P J England
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

Review 10.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981
View more
  12 in total

1.  Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.

Authors:  M Shahid; M G Martorana; J E Cottney; R J Marshall
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

Review 2.  Protein phosphorylation and compartments of cyclic AMP in the control of cardiac contraction.

Authors:  K J Murray; M L Reeves; P J England
Journal:  Mol Cell Biochem       Date:  1989-09-07       Impact factor: 3.396

3.  Direct evidence for a role of intramitochondrial Ca2+ in the regulation of oxidative phosphorylation in the stimulated rat heart. Studies using 31P n.m.r. and ruthenium red.

Authors:  J F Unitt; J G McCormack; D Reid; L K MacLachlan; P J England
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

4.  Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.

Authors:  M Shahid; I W Rodger
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

5.  Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts.

Authors:  P Karczewski; S Bartel; E G Krause
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

6.  In-vivo phosphorylation of the cardiac L-type calcium channel beta-subunit in response to catecholamines.

Authors:  H Haase; S Bartel; P Karczewski; I Morano; E G Krause
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

7.  Interactive effects of isoprenaline, forskolin and acetylcholine on Ca2+ current in frog ventricular myocytes.

Authors:  R Fischmeister; A Shrier
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

Review 8.  Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.

Authors:  P V Sulakhe; X T Vo
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

9.  Post-receptor defect accounts for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.

Authors:  J A Buczek-Thomas; S R Jaspers; T B Miller
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

10.  Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.

Authors:  J E Souness; R Brazdil; B K Diocee; R Jordan
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.